Business
Axxess Pharma Inc. Receives Signed Term Sheet From TCA Global Credit Master Fund to Secure US $4 Million Revolving Line of Credit
Axxess Pharma Inc. Receives Signed Term Sheet From TCA Global Credit Master Fund to Secure US $4 Million Revolving Line of Credit.
About this update from Allstar Health Brands, Inc.
[{"type":"text","content":"\n \n \n Axxess Pharma Inc. Receives Signed Term Sheet From TCA Global Credit Master Fund to Secure US $4 Million Revolving Line of Credit\n \n \nAxxess Pharma Inc. Receives Signed Term Sheet From TCA Global Credit Master Fund to Secure US $4 Million Revolving Line of Credit\n\nLine of Credit to Fund Worldwide Product Expansion and Generate Significant Revenue in Near-Term\n\n \n TORONTO, ON--(Marketwired - Oct 30, 2013) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce they have received a signed term sheet from TCA Global Credit Masters Fund (TCA) to secure a US $4 million revolving line of credit. Closing is anticipated within 14 days, pending final due diligence from Axxess Pharma Inc. and TCA. The revolving line of credit will enable Axxess Pharma to generate significant revenue in the near-term with high gross profit margins. \n This is expected to be the beginning of a long-term partnership between TCA Global and Axxess Pharma which will assist Axxess Pharma's capital needs as sales continue to grow. The line of credit will be used to aggressively develop, market and sell its line of pain relief and muscle recovery products worldwide, as well as develop and market a vitamins and minerals line under the TapouT brand name. Management will also release a second wave of TapouT branded products which will be a premium vitamins line. \n \"This is an exciting time for our company. The $4 million revolving line of credit with TCA will allow our company to expand worldwide, fulfil current orders and quickly become a multi-million dollar revenue generating company,\" said Dr. Bagi, President of Axxess Pharma Inc.\" Dr. Bagi further stated, \"In addition to our current TapouT products, we have additional products in the pipeline for release in 2014.\" \n About TCA Fund Management Group:\n TCA Fund Management Group (www.trafcap.com) as the Investment Manager for TCA Global Credit Master Fund L.P. acts as an advisor to many small companies from its offices in the United States, United Kingdom, and Australia. TCA is a short duration, absolute return fund specializing in senior-secured lending to small, mainly listed companies in the U.S., Canada, Western Europe, and Australia. The team has a level of domestic and cross-border expertise, long-standing experience...